Skip to main content

LPA1 inhibition induces metastatic dormancy in mouse models of breast cancer



This is really great!

A lysophosphatidic acid receptor 1 (LPAR1) inhibitor, known as Debio-0719, suppresses the development of metastases in mice by inducing cancer cell dormancy, according to astudy published August 21 in the Journal of the National Cancer Institute.

Metastasis is a main contributor to mortality in cancer patients.

Patients with “triple negative” breast cancer (tumour cells that are hormone receptor negative and express normal levels of the HER2 oncogene) are known to be at high risk for metastatic progression.

In addition, breast and prostate cancers are known for having variable but possibly long periods of dormancy, where the disease is silent.

Factors inducing or breaking a dormant state are poorly understood, but extending dormancy is considered a therapeutic goal.

To determine the effects of LPA1 inhibition on metastatic dormancy, Jean-Claude A. Marshall, MSc., Ph.D. of the Women’s Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, and colleagues analyzed primary tumour size, distant metastases and their molecular characteristics in two model systems of aggressive “triple negative” breast cancer metastasis, the murine 4T1 mammary carcinoma model and human MDA-MB-231 human breast carcinoma model. Debio-0719 or shRNA knockdown of LPA1 significantly inhibited metastasis formation without affecting primary tumour size.

Tumour cells found in distant organs, such as the lungs and liver of Debio-0719 treated mice, had ceased proliferation and exhibited other molecular hallmarks of dormancy.
LPA1 inhibition represents one of the first compounds to induce dormancy in metastatic sites in triple negative breast cancer.

The authors point out that LPA1 inhibition had no effect on the growth of the primary tumors in either model system. As such, it would not normally be considered further for drug development.
Their data suggest that alternative drug development approaches may identify compounds with novel activities, such as metastatic dormancy.

The authors point out that their study did not determine the duration of tumour dormancy, and that Debio-0719 and other LPA1 inhibitors should be tested in additional model systems.

However, they conclude: “With such inhibitors in hand, the interaction of dormancy pathways and standard of care therapeutics, radiation therapy, patient stress, and other important factors can be determined to develop a deeper picture of potential preventative and therapeutic scenarios.”
Labels:

Comments

Post a Comment

Popular posts from this blog

"Hard nipples" - areola or nipple skin

Someone once wrote"... when i get really cold, or get goosebumbs all over my body, the whole things really scrunch up, like, my entire areola scrunches itself up into a wrinkled little mound. it looks really weird and ugly, and i haven't ever seen other people's breasts do it. what is wrong with my areola/nipples??" The answer: Well nothing is wrong. This is what my areola does too. It's a normal reaction to the coldness or to irritation / stimulation. The little muscles in the areola do a similar goosebump thing as your other skin can do. People often call this phenomenon "hard nipples". Also note that skin on areola has less feeling or sensation to it than other areas of your body. If the areola was very sensitive, then breastfeeding would probably be quite uncomfortable because the baby pulls and tugs it! The nipples are sensitive but the sensitivity changes with hormonal changes, such as occur at mestrual cycle or pregnancy. Also this v...
8 comments
Read more

Mastectomy Drain Breast Cancer Treatment

The  purpose of drains after mastectomy  is to drain away the fluid that can gather in the armpit region or around the scar on the chest wall. Some people after mastectomy also find that fluid gathers around the shoulder blade area on their back - this seems more common if the muscle from the back has been used for  breast reconstruction  at the time the mastectomy was done. When mastectomy is done - and especially if the lymph nodes are removed from the axilla or armpit - then there is a lot of tissue fluid and lymph fluid left with no where to go. This fluid normally flows through the lymph channels but if they are cut then it can escape into the normal skin and muscle tissues. Your surgeon will place drains under your skin after mastectomy. These drains gather up the fluid and remove it to a bottle (or bottles) that you carry around with you. Some people use a  belt clip to attach the drain  to their waistband - making them more mobile. Others car...
8 comments
Read more

Pancreatic Cancer breakthrough

Published Today By  Ana Sandoiu Fact checked  by Jasmin Collier New research now published in the  Journal of Natural Products  shows that a vine compound is highly effective in the fight against treatment-resistant pancreatic cancer cells. #cancer #cells #pancreaticcancer #breakthrough #natural #journalofnaruralproducts #cure #survivor #iamstillawoman #Anasandiou #jasmincollier A type of rainforest vine may hold the key to effective cancer treatments.  Pancreatic cancer  is notoriously difficult to treat, and the condition has a poor outlook. According to the American Cancer Society (ACS), the 5-year survival rate for people with early-stage exocrine pancreatic cancer is  12–14 percent . A  new study  explains why that is and offers a potential solution. Gerhard Bringmann, a professor of organic chemistry at the Julius-Maximilians-Universität Würzburg in Germany.  Specifically, human pancreatic ...
9 comments
Read more